A preprint study shows that transplanted heart tissues change DNA methylation to match their recipient's biological age. Meanwhile, the US FDA approved its first clinical trial for a China-developed in vivo CAR-T-cell therapy treating blood cancers, highlighting China's rapid rise in the field.